The 5-HT receptor agonist prucalopride does not facilitate cholinergic neurotransmission in circular and longitudinal smooth muscle preparations of equine mid-jejunum.

Background: Postoperative ileus (POI) remains an important cause of death in horses. The recently developed selective 5-HT receptor agonists such as prucalopride target 5-HT receptors on myenteric cholinergic neurons to enhance acetylcholine release and GI motility. No clearcut in vitro evaluation whether highly selective 5-HT receptor agonists enhance submaximal cholinergic neurotransmission towards the muscle layer has been performed in horses.

Objectives: To identify functional 5-HT receptors in equine jejunum.

Study Design: In vitro experimental study.

Methods: Circular and longitudinal smooth muscle strips (mid-jejunum) were mounted in organ baths between 2 platinum electrodes allowing electrical field stimulation (EFS). To delineate the conditions to obtain purely cholinergic responses, voltage-response curves were studied. To investigate the influence of prucalopride and 5-HT, submaximal cholinergic contractions at a single voltage were induced.

Results: In circular and longitudinal strips, EFS induced voltage-dependent neurogenic on-contractions when the bathing medium contained a NO-synthesis inhibitor and apamin to prevent inhibitory responses to NO and ATP. Contractions at a voltage inducing 50% of maximal amplitude were cholinergic, as they were blocked by atropine. These contractions were not influenced by prucalopride (up to 3μM), even in the presence of the phosphodiesterase inhibitor isobutyl-methyl-xanthine to inhibit breakdown of the second messenger of 5-HT receptors, cAMP. Also the full 5-HT receptor agonist 5-HT did not influence the EFS-induced submaximal cholinergic contractions. Moreover, prucalopride did not influence muscle tone continuously enhanced with KCl.

Conclusions: There are no functional 5-HT receptors on myenteric cholinergic neurons nor muscular 5-HT receptors in equine jejunum.